$AVAH
Aveanna Healthcare Holdings, Inc.

2022 Q2 Form 10-Q Financial Statement

#000095017022009347 Filed on May 11, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2021 Q2
Revenue $450.5M $417.2M
YoY Change 8.0% 18.65%
Cost Of Revenue $305.7M $285.5M
YoY Change 7.08%
Gross Profit $144.8M $131.7M
YoY Change 9.98% 23.5%
Gross Profit Margin 32.15% 31.57%
Selling, General & Admin $88.74M $69.37M
YoY Change 27.92% 25.86%
% of Gross Profit 61.28% 52.68%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.819M $4.850M
YoY Change 19.98%
% of Gross Profit 4.02% 3.68%
Operating Expenses $88.74M $69.37M
YoY Change 27.92% 25.86%
Operating Profit $13.78M $28.30M
YoY Change -51.31% -154.46%
Interest Expense $22.36M $22.43M
YoY Change -0.27% 19.0%
% of Operating Profit 162.34% 79.25%
Other Income/Expense, Net $36.46M $159.0K
YoY Change 22828.93% -72.91%
Pretax Income $27.93M $6.107M
YoY Change 357.36% -108.11%
Income Tax $2.600M $300.0K
% Of Pretax Income 9.31% 4.91%
Net Earnings $25.33M $5.798M
YoY Change 336.94% -107.48%
Net Earnings / Revenue 5.62% 1.39%
Basic Earnings Per Share $0.14 $0.04
Diluted Earnings Per Share $0.14 $0.04
COMMON SHARES
Basic Shares Outstanding 184.9M 142.1M
Diluted Shares Outstanding 185.4M 146.3M

Balance Sheet

Concept 2022 Q2 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.44M $67.10M
YoY Change -74.01%
Cash & Equivalents $17.44M $67.11M
Short-Term Investments
Other Short-Term Assets $5.649M $9.394M
YoY Change -39.87%
Inventory
Prepaid Expenses $15.33M $12.61M
Receivables $240.9M $195.7M
Other Receivables $0.00 $0.00
Total Short-Term Assets $286.2M $293.2M
YoY Change -2.39%
LONG-TERM ASSETS
Property, Plant & Equipment $29.49M $32.17M
YoY Change -8.32%
Goodwill $1.837B $1.317B
YoY Change 39.48%
Intangibles $102.2M $72.27M
YoY Change 41.42%
Long-Term Investments
YoY Change
Other Assets $41.79M $9.426M
YoY Change 343.33%
Total Long-Term Assets $2.090B $1.505B
YoY Change 38.9%
TOTAL ASSETS
Total Short-Term Assets $286.2M $293.2M
Total Long-Term Assets $2.090B $1.505B
Total Assets $2.376B $1.798B
YoY Change 32.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $57.31M $41.90M
YoY Change 36.78%
Accrued Expenses $66.70M $63.00M
YoY Change 5.88%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $1.800M
YoY Change -100.0%
Long-Term Debt Due $8.600M $11.72M
YoY Change -26.65%
Total Short-Term Liabilities $367.8M $207.5M
YoY Change 77.26%
LONG-TERM LIABILITIES
Long-Term Debt $1.225B $1.163B
YoY Change 5.36%
Other Long-Term Liabilities $1.093M $28.08M
YoY Change -96.11%
Total Long-Term Liabilities $1.227B $1.191B
YoY Change 2.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $367.8M $207.5M
Total Long-Term Liabilities $1.227B $1.191B
Total Liabilities $1.708B $1.524B
YoY Change 12.06%
SHAREHOLDERS EQUITY
Retained Earnings -$549.3M -$451.8M
YoY Change 21.58%
Common Stock $1.215B $723.4M
YoY Change 68.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $666.0M $271.5M
YoY Change
Total Liabilities & Shareholders Equity $2.376B $1.798B
YoY Change 32.17%

Cashflow Statement

Concept 2022 Q2 2021 Q2
OPERATING ACTIVITIES
Net Income $25.33M $5.798M
YoY Change 336.94% -107.48%
Depreciation, Depletion And Amortization $5.819M $4.850M
YoY Change 19.98%
Cash From Operating Activities -$9.476M -$32.91M
YoY Change -71.21%
INVESTING ACTIVITIES
Capital Expenditures $3.984M $2.665M
YoY Change 49.49%
Acquisitions $1.394M $500.0K
YoY Change 178.8%
Other Investing Activities -$12.66M -$500.0K
YoY Change 2431.8%
Cash From Investing Activities -$16.64M -$3.165M
YoY Change 425.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.07M -34.16M
YoY Change -138.25%
NET CHANGE
Cash From Operating Activities -9.476M -32.91M
Cash From Investing Activities -16.64M -3.165M
Cash From Financing Activities 13.07M -34.16M
Net Change In Cash -13.05M -70.24M
YoY Change -81.42%
FREE CASH FLOW
Cash From Operating Activities -$9.476M -$32.91M
Capital Expenditures $3.984M $2.665M
Free Cash Flow -$13.46M -$35.58M
YoY Change -62.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001832332
CY2022Q2 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 dei Document Type
DocumentType
10-Q
CY2022Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q2 dei Document Period End Date
DocumentPeriodEndDate
2022-04-02
CY2022Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q2 dei Entity File Number
EntityFileNumber
001-40362
CY2022Q2 dei Entity Registrant Name
EntityRegistrantName
Aveanna Healthcare Holdings Inc.
CY2022Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-4717209
CY2022Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
400 Interstate North Parkway SE
CY2022Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
CY2022Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2022Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30339
CY2022Q2 dei Local Phone Number
LocalPhoneNumber
441-1580
CY2022Q2 dei City Area Code
CityAreaCode
770
CY2022Q2 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2022Q2 dei Trading Symbol
TradingSymbol
AVAH
CY2022Q2 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q2 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
184732268
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17439000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30490000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
240895000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
218917000
CY2022Q2 avah Receivables Under Insured Programs Current
ReceivablesUnderInsuredProgramsCurrent
6900000
CY2022Q1 avah Receivables Under Insured Programs Current
ReceivablesUnderInsuredProgramsCurrent
6373000
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
15330000
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
14233000
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
5649000
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
9202000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
286213000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
279215000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29491000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31374000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
51289000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
51992000
CY2022Q2 us-gaap Goodwill
Goodwill
1837437000
CY2022Q1 us-gaap Goodwill
Goodwill
1835580000
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
102196000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
102851000
CY2022Q2 avah Receivables Under Insured Programs Noncurrent
ReceivablesUnderInsuredProgramsNoncurrent
27615000
CY2022Q1 avah Receivables Under Insured Programs Noncurrent
ReceivablesUnderInsuredProgramsNoncurrent
25530000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
41788000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7829000
CY2022Q2 us-gaap Assets
Assets
2376029000
CY2022Q1 us-gaap Assets
Assets
2334371000
CY2022Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
57309000
CY2022Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
52624000
CY2022Q2 avah Accrued Payroll And Employee Benefits
AccruedPayrollAndEmployeeBenefits
53019000
CY2022Q1 avah Accrued Payroll And Employee Benefits
AccruedPayrollAndEmployeeBenefits
54565000
CY2022Q2 avah Current Portion Of Insurance Reserves Insured Programs
CurrentPortionOfInsuranceReservesInsuredPrograms
6900000
CY2022Q1 avah Current Portion Of Insurance Reserves Insured Programs
CurrentPortionOfInsuranceReservesInsuredPrograms
6373000
CY2022Q2 avah Current Portion Of Insurance Reserves
CurrentPortionOfInsuranceReserves
14532000
CY2022Q2 avah Securitization Obligations
SecuritizationObligations
140000000
CY2022Q1 avah Current Portion Of Insurance Reserves
CurrentPortionOfInsuranceReserves
13466000
CY2022Q1 avah Securitization Obligations
SecuritizationObligations
120000000
CY2022Q2 us-gaap Loans Payable Current
LoansPayableCurrent
8600000
CY2022Q1 us-gaap Loans Payable Current
LoansPayableCurrent
8600000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13685000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13534000
CY2022Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
25523000
CY2022Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
25523000
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
48222000
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
50146000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
367790000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
344831000
CY2022Q2 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
1225428000
CY2022Q1 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
1226517000
CY2022Q2 avah Long Term Insurance Reserves Insured Programs
LongTermInsuranceReservesInsuredPrograms
27615000
CY2022Q1 avah Long Term Insurance Reserves Insured Programs
LongTermInsuranceReservesInsuredPrograms
25530000
CY2022Q2 avah Long Term Insurance Reserves
LongTermInsuranceReserves
37892000
CY2022Q1 avah Long Term Insurance Reserves
LongTermInsuranceReserves
35122000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
43651000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
44682000
CY2022Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4460000
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3046000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1093000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16692000
CY2022Q2 us-gaap Liabilities
Liabilities
1707929000
CY2022Q1 us-gaap Liabilities
Liabilities
1696420000
CY2022Q2 avah Deferred Restricted Stock Units
DeferredRestrictedStockUnits
2135000
CY2022Q1 avah Deferred Restricted Stock Units
DeferredRestrictedStockUnits
2135000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
184732268
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
184732268
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
184732268
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
184732268
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
1847000
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
1847000
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1213460000
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1208645000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-549342000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-574676000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
665965000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
635816000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2376029000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2334371000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
450534000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
417160000
CY2022Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
305708000
CY2021Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
285477000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
88743000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
69372000
CY2022Q2 avah Corporate Expenses
CorporateExpenses
36567000
CY2021Q2 avah Corporate Expenses
CorporateExpenses
27399000
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5819000
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4848000
CY2022Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
91000
CY2021Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1768000
CY2022Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
170000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
13776000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
28296000
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
62000
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
77000
CY2022Q2 us-gaap Interest Expense
InterestExpense
22364000
CY2021Q2 us-gaap Interest Expense
InterestExpense
22425000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
36457000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
159000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
27931000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6107000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2597000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
309000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
25334000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
5798000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
184927000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142123000
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
185427000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
146266000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
635816000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4815000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
25334000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
665965000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
265034000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
712000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
5798000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
271544000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
25334000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
5798000
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5819000
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4848000
CY2022Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1740000
CY2021Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2140000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
4193000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3550000
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
4815000
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
712000
CY2022Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
112000
CY2021Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
4000
CY2022Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
38256000
CY2021Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2820000
CY2022Q2 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
170000
CY2022Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1414000
CY2021Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
694000
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
22552000
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
22852000
CY2022Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1253000
CY2021Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1684000
CY2022Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3554000
CY2021Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1957000
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5199000
CY2021Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-15763000
CY2022Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1546000
CY2021Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-7595000
CY2022Q2 us-gaap Increase Decrease In Self Insurance Reserve
IncreaseDecreaseInSelfInsuranceReserve
3836000
CY2021Q2 us-gaap Increase Decrease In Self Insurance Reserve
IncreaseDecreaseInSelfInsuranceReserve
3466000
CY2022Q2 avah Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-4370000
CY2021Q2 avah Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-4126000
CY2022Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-2879000
CY2021Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1232000
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9476000
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32911000
CY2022Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1394000
CY2021Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
500000
CY2022Q2 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
460000
CY2022Q2 us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
11725000
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3984000
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2665000
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16643000
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3165000
CY2022Q2 us-gaap Proceeds From Accounts Receivable Securitization
ProceedsFromAccountsReceivableSecuritization
30000000
CY2022Q2 us-gaap Repayments Of Accounts Receivable Securitization
RepaymentsOfAccountsReceivableSecuritization
10000000
CY2022Q2 avah Repayment Of Term Loans
RepaymentOfTermLoans
2150000
CY2022Q2 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2551000
CY2021Q2 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3535000
CY2021Q2 avah Repayment Of Government Stimulus Funds
RepaymentOfGovernmentStimulusFunds
29444000
CY2022Q2 avah Payments Of Financing Lease Obligations
PaymentsOfFinancingLeaseObligations
181000
CY2021Q2 avah Payments Of Financing Lease Obligations
PaymentsOfFinancingLeaseObligations
203000
CY2021Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
786000
CY2021Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
196000
CY2022Q2 us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
2050000
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13068000
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-34164000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13051000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-70240000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30490000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
137345000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17439000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
67105000
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
16136000
CY2021Q2 us-gaap Interest Paid Net
InterestPaidNet
20207000
CY2022Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1110000
CY2021Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2520000
CY2021Q2 avah Offering Costs Included In Accounts Payable And Other Accrued Liabilities
OfferingCostsIncludedInAccountsPayableAndOtherAccruedLiabilities
1874000
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-161000
CY2021Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-202000
CY2022Q2 us-gaap Nature Of Operations
NatureOfOperations
<p id="notes_to_unaudited_consolidated_financia" style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1. DESCRIPTION</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> OF BUSINESS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Aveanna Healthcare Holdings Inc. (together with its consolidated subsidiaries, referred to herein as the “Company”) is headquartered in Atlanta, Georgia and has locations in </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> states with concentrations in California, Texas and Pennsylvania, providing a broad range of pediatric and adult healthcare services including nursing, hospice, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically fragile and chronically ill children and adults, as well as delivery of enteral nutrition and other products to patients. The Company also provides case management services in order to assist families and patients by coordinating the provision of services between insurers or other payers, physicians, hospitals, and other healthcare providers. In addition, the Company provides respite healthcare services, which are temporary care provider services provided in relief of the patient’s normal caregiver. The Company’s services are designed to provide a high quality, lower cost alternative to prolonged hospitalization.</span></p>
CY2022Q2 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
33
CY2022Q2 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company’s accounting and reporting policies conform with U.S. GAAP. In preparing the consolidated financial statements, the Company is required to make estimates and assumptions that impact the amounts reported in these consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.</span></p>
CY2022Q2 avah Estimated Price Concession
EstimatedPriceConcession
57800000
CY2022Q1 avah Estimated Price Concession
EstimatedPriceConcession
55800000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2022Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1270700000
CY2022Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1272850000
CY2022Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
36672000
CY2022Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
37733000
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
1234028000
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
1235117000
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
8600000
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
8600000
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1225428000
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1226517000
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
1700000
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
2100000
CY2022Q2 avah Swingline Loan
SwinglineLoan
0
CY2022Q1 avah Swingline Loan
SwinglineLoan
0
CY2022Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1270700000
CY2022Q2 us-gaap Derivative Assets
DerivativeAssets
34639000
CY2022Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
15342000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2600000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.087
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.048
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q4 us-gaap Malpractice Insurance Deductible1
MalpracticeInsuranceDeductible1
1000000.0
CY2021Q4 us-gaap Malpractice Insurance Maximum Coverage Per Incident
MalpracticeInsuranceMaximumCoveragePerIncident
5500000
CY2021Q3 us-gaap Malpractice Insurance Deductible1
MalpracticeInsuranceDeductible1
500000
CY2021Q3 us-gaap Malpractice Insurance Maximum Coverage Per Incident
MalpracticeInsuranceMaximumCoveragePerIncident
6000000.0
CY2022Q2 us-gaap Self Insurance Reserve
SelfInsuranceReserve
86900000
CY2022Q1 us-gaap Self Insurance Reserve
SelfInsuranceReserve
80500000
CY2018Q4 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
75000000.0
CY2019Q4 avah Break Up Fee Payable
BreakUpFeePayable
0
CY2022Q2 us-gaap Loss Contingency Name Of Defendant
LossContingencyNameOfDefendant
Epic/Freedom, LLC (“Seller”), Webster Capital Corporation, and Webster Equity Partners (collectively, the “Defendants”)
CY2020Q3 us-gaap Escrow Deposit
EscrowDeposit
7100000
CY2021 avah Provider Relief Fund Payments Received Cares Act
ProviderReliefFundPaymentsReceivedCARESAct
25100000
CY2021Q4 avah Provider Relief Fund Payments Received Cares Act
ProviderReliefFundPaymentsReceivedCARESAct
2500000
CY2022Q2 avah Incremental Percentage Of Deferred Payment Of Employer Portion Of Social Security Taxes
IncrementalPercentageOfDeferredPaymentOfEmployerPortionOfSocialSecurityTaxes
0.50
CY2021Q4 avah Percentage Of Social Security Tax Due Cares Act
PercentageOfSocialSecurityTaxDueCARESAct
0.50
CY2022Q4 avah Percentage Of Social Security Tax Due Cares Act
PercentageOfSocialSecurityTaxDueCARESAct
0.50
CY2022Q2 avah Deferred Social Security Tax Cares Act
DeferredSocialSecurityTaxCARESAct
25500000
CY2022Q1 avah Deferred Social Security Tax Cares Act
DeferredSocialSecurityTaxCARESAct
25500000
CY2021Q1 avah Arpa Recovery Funds
ArpaRecoveryFunds
350000000000
CY2022Q2 avah Arpa Recovery Funds
ArpaRecoveryFunds
3100000
CY2022Q2 us-gaap Management Fee Expense
ManagementFeeExpense
0
CY2021Q2 us-gaap Management Fee Expense
ManagementFeeExpense
900000
CY2022Q2 avah Advisory Services Expense Outstanding
AdvisoryServicesExpenseOutstanding
0
CY2022Q1 avah Advisory Services Expense Outstanding
AdvisoryServicesExpenseOutstanding
0
CY2022Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2022Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
450534000
CY2022Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
305708000
CY2022Q2 us-gaap Gross Profit
GrossProfit
144826000
CY2022Q2 avah Gross Margin Percentage
GrossMarginPercentage
0.321
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
417160000
CY2021Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
285477000
CY2021Q2 us-gaap Gross Profit
GrossProfit
131683000
CY2021Q2 avah Gross Margin Percentage
GrossMarginPercentage
0.316
CY2022Q2 us-gaap Gross Profit
GrossProfit
144826000
CY2021Q2 us-gaap Gross Profit
GrossProfit
131683000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
88743000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
69372000
CY2022Q2 avah Corporate Expenses
CorporateExpenses
36567000
CY2021Q2 avah Corporate Expenses
CorporateExpenses
27399000
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5819000
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4848000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
13776000
CY2022Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
91000
CY2021Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1768000
CY2022Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
170000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
28296000
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
62000
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
77000
CY2022Q2 us-gaap Interest Expense
InterestExpense
22364000
CY2021Q2 us-gaap Interest Expense
InterestExpense
22425000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
36457000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
159000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
27931000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6107000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
25334000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
5798000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
184927000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142123000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
185427000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
146266000
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04

Files In Submission

Name View Source Status
0000950170-22-009347-index-headers.html Edgar Link pending
0000950170-22-009347-index.html Edgar Link pending
0000950170-22-009347.txt Edgar Link pending
0000950170-22-009347-xbrl.zip Edgar Link pending
avah-20220402.htm Edgar Link pending
avah-20220402.xsd Edgar Link pending
avah-20220402_cal.xml Edgar Link unprocessable
avah-20220402_def.xml Edgar Link unprocessable
avah-20220402_htm.xml Edgar Link completed
avah-20220402_lab.xml Edgar Link unprocessable
avah-20220402_pre.xml Edgar Link unprocessable
avah-ex31_1.htm Edgar Link pending
avah-ex31_2.htm Edgar Link pending
avah-ex32_1.htm Edgar Link pending
avah-ex32_2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img22824085_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending